Recall Register

RXQ Compounding LLC: FDA recalls

Newest recall start date in this list: . Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC…

FDA enforcement events from 2017 to 2019; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name RXQ Compounding LLC as the recalling firm in 3 events. The events have 88 product records. The recalls started from 2017 to 2019. All the events are drug recalls. By FDA enforcement events, RXQ Compounding LLC is number 1,114 of 1,629 firms that have a page. Events that RXQ Compounding LLC started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

3 events, newest first.

FDA enforcement events of RXQ Compounding LLC
InitiatedProduct (first record)TypeClassRecordsStatus
19 Jun 2019Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10DrugClass II86Terminated
25 Sep 2018Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450DrugClass II1Terminated
25 Sep 2017methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10DrugClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

RXQ Compounding LLC: events for each product type
TypeEvents
Drug3
RXQ Compounding LLC: events in each class
ClassEvents
Class II3
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of RXQ Compounding LLC, by the year that the recall started. The largest year is 2017, with 1 event.

Official channels

Cite this page

Recall Register. RXQ Compounding LLC: FDA recalls. https://recallregister.com/firm/rxq-compounding-llc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
OH

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of RXQ Compounding LLC have?
Class II: 3 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of RXQ Compounding LLC?
FDA event 83074, which the firm started on 19 Jun 2019. The first product in the record is: Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10
How many FDA recalls of RXQ Compounding LLC have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.